Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Authors

Jonathan Pan, Thomas Jefferson UniversityFollow
Daniel Altman, Thomas Jefferson UniversityFollow
Lindsay Wilde, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

10-22-2020

Comments

This article is the author’s final published version in Frontiers in Oncology, Volume 10, October 2020, Article number 576924.

The published version is available at https://doi.org/10.3389/fonc.2020.576924. Copyright © Pan et al.

Recommended Citation

Pan, Jonathan; Altman, Daniel; and Wilde, Lindsay, "Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome." (2020). Department of Medical Oncology Faculty Papers. Paper 128.
https://jdc.jefferson.edu/medoncfp/128

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

PubMed ID

33194691

Language

English